| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 102, 271-281, Copyright © 1981 by American Society for Investigative Pathology
REVIEWS |
JL Farber, KR Chien and S Mittnacht Jr
Cells made ischemic rapidly manifest many distinct structural and functional alterations as a consequence of the depletion of their energy stores. In attempting to determine which of these are causally related to the eventual cell death, the authors have emphasized the relationship to the reversibility of the ischemic injury. Two phenomena have consistently characterized irreversibly in contrast to reversibly injured ischemic cells: the inability to restore mitochondrial function and evidence of plasma membrane damage. Studies in the authors' laboratory are reviewed that have focused on the pathogenesis, biochemical nature, and the relationship to irreversible cell injury of both of these alterations. A number of mitochondrial abnormalities are related to changes in long-chain acyl-CoA metabolism with inhibition of adenine nucleotide translocation and potentiation of a Ca2+-dependent increase in the permeability of the inner mitochondrial membrane. These changes are reversible upon reoxygenation only when the large increase in intracellular Ca2+ content that accompanies the phospholipid depletion from other cellular membranes is prevented. This disorder in phospholipid metabolism is felt to be the critical lesion that produces irreversible cell injury in ischemia. It affects the endoplasmic and sarcoplasmic reticular membranes of liver and myocardial cells, respectively, and probably the plasma membranes of both. It is prevented by pretreatment with chlorpromazine. An activation of endogenous phospholipases by an elevated, cytosolic free Ca2+ ion concentration is suggested as the mechanism underlying this phospholipid disturbance. The central role of intracellular Ca2+ in the initiation and functional consequences of ischemic cell injury are emphasized.
This article has been cited by other articles:
 |
|
 |
|
  T. Kotani, A. Kobata, E. Nakamura, K. Amagase, and K. Takeuchi Roles of Cyclooxygenase-2 and Prostacyclin/IP Receptors in Mucosal Defense against Ischemia/Reperfusion Injury in Mouse Stomach J. Pharmacol. Exp. Ther., February 1, 2006; 316(2): 547 - 555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Padanilam Cell death induced by acute renal injury: a perspective on the contributions of apoptosis and necrosis Am J Physiol Renal Physiol, April 1, 2003; 284(4): F608 - F627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. SEIFALIAN, E.-H. EL-DESOKY, D. T. DELPY, and B. R. DAVIDSON Effect of graded hypoxia on the rat hepatic tissue oxygenation and energy metabolism monitored by near-infrared and 31P nuclear magnetic resonance spectroscopy FASEB J, December 1, 2001; 15(14): 2642 - 2648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Erkasap and E. Ates L-Arginine-enriched preservation solution decreases ischaemia/reperfusion injury in canine kidneys after long-term cold storage Nephrol. Dial. Transplant., August 1, 2000; 15(8): 1224 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Lipton Ischemic Cell Death in Brain Neurons Physiol Rev, October 1, 1999; 79(4): 1431 - 1568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. H. ERDEN, N. TUNCEL, Y. AYDYN, V. SAHINTURK, M. KOSAR, and M. TUNCEL The Effect of Vasoactive Intestinal Peptide (VIP) and Inhibition of Nitric Oxide on Renal Tissue Injury of Rats Exposed to Hemorrhagic Ischemia and Retransfusion: A Possible Interaction Mechanism among Mast Cells and Tissue Histamine Ann. N.Y. Acad. Sci., December 11, 1998; 865(1): 570 - 581. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, N. Jiang, C. Powers, M. Chopp, and B. B. Johansson Neuronal Damage and Plasticity Identified by Microtubule-Associated Protein 2, Growth-Associated Protein 43, and Cyclin D1 Immunoreactivity After Focal Cerebral Ischemia in Rats • Editorial Comment Stroke, September 1, 1998; 29(9): 1972 - 1981. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. R. Herzog, M. L. Schlossberg, K. S. MacMurdy, L. R. Edenbaum, M. J. Gerber, R. A. Vogel, and V. L. Serebruany Timing of Magnesium Therapy Affects Experimental Infarct Size Circulation, November 1, 1995; 92(9): 2622 - 2626. [Abstract] [Full Text]
|
|
|
|
|
|
J. H. Garcia, K.-F. Liu, and K.-L. Ho Neuronal Necrosis After Middle Cerebral Artery Occlusion in Wistar Rats Progresses at Different Time Intervals in the Caudoputamen and the Cortex Stroke, April 1, 1995; 26(4): 636 - 643. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. R. Wechsler Analytic Reviews : Potential New Therapies for Acute Ischemic Stroke J Intensive Care Med, September 1, 1988; 3(5): 258 - 264. [Abstract] [PDF]
|
|
|
|
 |
|
 P. Hochachka Defense strategies against hypoxia and hypothermia Science, January 17, 1986; 231(4735): 234 - 241. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
